YOU ARE HERE: LAT HomeCollectionsStephen E Straus

Stephen E Straus

November 15, 2001 | From Times Wire Reports
There is no evidence that alternative medicines, including some promoted on the Internet, are effective in treating anthrax or other biological agents, a leading government scientist said. Certain natural treatments could interfere with proven antibiotics, and there is little reason to believe they hold promise in responding to bioterrorist attacks, said Dr. Stephen E. Straus, director of the National Center for Complimentary and Alternative Medicine.
June 15, 1986
People who are infected with genital herpes but show no outward signs of the disease can still pass it on to their sexual partners, and this may be a common way in which the ailment is transmitted, researchers report. Experts now believe that perhaps as many as half of all adult Americans already have the disease, but most of them don't know it. Dr. Stephen E.
December 7, 1987
Scientists believe that they have found a genetic "off" switch that keeps the herpes virus dormant in the body, a discovery that could mean new strategies for controlling a variety of viruses. They found the genetic trigger in herpes simplex virus type 1, the virus that causes cold sores. They believe the same mechanism controls its cousin, herpes simplex virus type 2, which causes genital herpes.
December 21, 2004 | From Associated Press
The ancient Chinese therapy of acupuncture can help ease pain and improve movement for people with arthritis of the knee, a study concludes. "For the first time, a clinical trial with sufficient rigor, size and duration has shown that acupuncture reduces the pain and functional impairment of osteoarthritis of the knee," said Dr. Stephen E. Straus, director of the National Center for Complementary and Alternative Medicine.
June 7, 1986 | ROBERT STEINBROOK, Times Medical Writer
Sandy Schmidt, 42, came down with the mysterious illness soon after she ran a marathon in San Francisco last July. She got better before becoming sick again this spring, forcing her to quit her job as a business office manager. Running even one mile now would "put me in bed for a day and a half," she said.
May 1, 1987 | ROBERT STEINBROOK, Times Medical Writer
The Epstein-Barr virus is often blamed for causing a chronic fatigue syndrome that bears its name. But according to two studies being published today in the Journal of the American Medical Assn., the virus appears to have nothing to do with the disorder in many cases. The studies, however, are likely to frustrate both patients and physicians. While they confirm the existence of the ailment, they shed little light on its actual cause or how to treat it.
July 28, 2005 | Karen Kaplan, Times Staff Writer
Echinacea, the popular herbal remedy used for the common cold, does not ward off runny noses, sore throats or headaches, nor does it help speed recovery from cold symptoms, according to the results of a broad clinical trial reported today in the New England Journal of Medicine. Taken with other recent studies that showed no benefit from echinacea, the new findings shift the burden of proof to proponents of herbal products to demonstrate that the plant has medicinal value, researchers said.
Definitive though it may have sounded, the recent federal study of St. John's wort still hasn't answered all the questions about the herb's effectiveness in treating depression. Researchers reported last week that the herb failed to alleviate moderately severe cases of the illness, which can interfere with work, sleep, eating habits and personal relationships.
Researchers are on the brink of perfecting a vaccine that may prevent shingles--a disease that most often afflicts the elderly and can produce blisters so painful that it has driven some to suicide. The last phase of research, launched in June, could produce a marketable vaccine within five years--just in time for the first wave of baby boomers entering their 60s.
April 9, 2004 | David Willman, Times Staff Writer
The National Institutes of Health should publicly disclose all drug company payments to its scientists, and should bar employees from accepting stock or stock options from industry, according to a draft report from a panel examining conflict of interest at the agency. The report stops short of calling for a ban on company consulting deals with NIH scientists, but it recommends that the agency block top officials from participating in such arrangements.
Los Angeles Times Articles